Chromenopyrimidinone exhibit antitumor effects through inhibition of CAP1 (Adenylyl cyclase-associated protein 1) expression in hepatocellular carcinoma.
Chem Biol Interact
; 365: 110066, 2022 Sep 25.
Article
in En
| MEDLINE
| ID: mdl-35931200
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrimidinones
/
Carcinoma, Hepatocellular
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Chem Biol Interact
Year:
2022
Document type:
Article
Affiliation country:
South Korea
Country of publication:
Ireland